Literature DB >> 2254775

Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome.

S F Lanes1, K J Rothman.   

Abstract

Tampon use has been identified as a major risk factor for toxic shock syndrome, although the etiologic role of tampons is not clearly understood. Two epidemiologic studies conducted to date have reported an association between tampon absorbency and risk of toxic shock syndrome. This finding is not corroborated by laboratory studies, however, which have suggested that absorbency may be a marker for other characteristics that create an environment conductive to the elaboration of toxic shock syndrome toxin 1. We used data from the previously reported Tri-state study to estimate simultaneously the effects of tampon oxygen content, absorbency and chemical composition. Although the data are sparse, oxygen content was more strongly associated with risk of toxic shock syndrome than either absorbency or chemical composition. The results suggest that it may be possible to develop a highly absorbent tampon that is not associated with a high risk of toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254775     DOI: 10.1016/0895-4356(90)90105-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

Review 1.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

2.  Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.

Authors:  Rita Kansal; Catherine Davis; Melanie Hansmann; Jon Seymour; Jeffrey Parsonnet; Paul Modern; Steve Gilbert; Malak Kotb
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

3.  A study on the microbial quality of sealed products for feminine hygiene.

Authors:  R Briancesco; S Paduano; M Semproni; L Bonadonna
Journal:  J Prev Med Hyg       Date:  2018-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.